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AKTIP is a shelterin-interacting protein required for replication of telomeric
DNA. Here, we show that AKTIP biochemically interacts with A- and B-type
lamins and affects lamin A, but not lamin C or B, expression. In interphase
cells, AKTIP localizes at the nuclear rim and in discrete regions of the
nucleoplasm just like lamins. Double immunostaining revealed that
AKTIP partially co-localizes with lamin B1 and lamin A/C in interphase
cells, and that proper AKTIP localization requires functional lamin A. In
mitotic cells, AKTIP is enriched at the spindle poles and at the midbody
of late telophase cells similar to lamin B1. AKTIP-depleted cells show senes-
cence-associated markers and recapitulate several aspects of the progeroid
phenotype. Collectively, our results indicate that AKTIP is a new player in
lamin-related processes, including those that govern nuclear architecture,
telomere homeostasis and cellular senescence.1. Background
The nuclear lamina is a structure located between the nuclear membrane and
the chromatin; it plays a scaffolding role within the nucleus and has been implicated
in diverse processes including the control of nuclear architecture, DNA replication
and repair, transcriptional regulation, and maintenance of telomere homeostasis
[1–6]. A- and B-type lamins are the main components of the nuclear lamina;
B-type lamins are expressed in most cell types, whereas lamin A/C expression is
restricted to differentiated cells [7,8]. In interphase cells, lamins are mainly detected
at the nuclear periphery, but are also found in discrete intranuclear aggregates
associated with DNA replication foci or transcriptionally active areas [7]. At the
onset of mitosis the lamina disassembles; B-type lamins concentrate in the spindle
matrix, whereas A-type lamins remain diffuse in the cytoplasm. At the end of
mitosis (telophase), the lamins reassemble to form the nuclear lamina [7,9,10].
In humans, there are three lamin genes: LMNA, LMNB1 and LMNB2. Lamins
A and C are alternatively spliced isoforms of the LMNA gene. Lamins B1 and B2
are the products of the LMNB1 and LMNB2 genes. Lamins A, B1 and B2 are
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2initially synthesized as precursors, known as prelamins,
which are processed into mature lamins through a sequential
series of post-translational modifications [1]. Mutations in the
human lamin genes result in a wide range of diseases, includ-
ing the Hutchinson-Gilford progeria syndrome (HGPS) [11]
and mandibuloacral dysplasia type A (MADA) [12]. HGPS
patients suffer from premature ageing; their cells exhibit an
accumulation of a truncated form of lamin A, which causes
early senescence, dismorphic nuclei, abnormal intranuclear
chromatin distribution and telomere attrition [3,13]. MADA
patients share with HGPS patients a premature ageing pheno-
type. MADA cells display an accumulation of prelamin A, an
altered chromatin organization and dislocation of nuclear
envelope-associated proteins [12,14].
Lamin-related functions and pathologies are largely depen-
dent upon lamin interplay with multiple interacting partners.
For example, the fact that the Ig-fold motif at the lamin C-termi-
nus binds proliferating cell nuclear antigen (PCNA) suggests a
mechanistic path for lamin implication in DNA replication [15].
Similarly, the lamin A/C interaction with 53BP1 to promote
the DNA damage response (DDR) accounts for the DNA
repair defects observed in lamin mutants [16]. The chromatin
defects observed in HGPS patient cells probably reflect the
interaction of lamins with the NURD chromatin remodelling
complex [17]. Loss of another lamin-interacting protein, the
Suv39h1 methyltransferase, has been shown to improve
DNA repair and extend the lifespan of a progeroid mouse
model with impaired prelamin A maturation, suggesting that
HGPS causes Suv39h1-mediated epigenetic alterations in the
chromatin [18]. Finally, lamin A/C interaction with the
shelterin component TRF2 and the association of the lamina-
associated polypeptide-a (LAP2a) with telomeres provide
evidence for a role of lamin A and progerin in telomere homeo-
stasis [6]. Although the biological significance of many of the
lamins’ interactions is not precisely defined, there is no doubt
that further studies on these interactions and the discovery
of new lamin-interacting partners will be instrumental to
understand the mechanistic bases of the role of lamin in
physiological and pathological processes [19].
Here, we provide a functional characterization of an
additional lamin-interacting protein, AKTIP. AKTIP belongs
to the ubiquitin E2 variant (UEV) enzyme subfamily, which
comprises proteins that share sequence similarity with E2s
but lack the conserved cysteine residue that is critical for
the canonical E2 catalytic activity [20]. UEV functions are
still ill defined; it has been suggested that they can act in com-
bination with E2 conjugating enzymes in ubiquitylation
processes [21,22]. We have recently shown that AKTIP and
its Drosophila orthologue Pendolino (Peo) play roles at telo-
meres [23,24]. AKTIP directly binds the shelterin proteins
TRF1 and TRF2 and interacts with the PCNA and RPA70
DNA replication factors, and its depletion results in general
impairment of DNA synthesis and defective telomere replica-
tion. Collectively, our results indicate that AKTIP works in
concert with TRF1 to ensure proper telomere replication.
The finding that both AKTIP and lamins interact with telo-
meres and with PCNA [3,6,23,25], along with the enrichment
of AKTIP at the nuclear rim [23], prompted us to investigate
whether AKTIP interacts with lamins. Here, we show that
AKTIP co-purifies with A- and B-type lamins and partially co-
localizes with lamins in interphase nuclei. In addition, we show
that AKTIP depletion lowers lamin A expression and induces
senescence hallmarks in human primary fibroblasts (HPFs).2. Material and methods
2.1. Cells, vectors and virus
Human foreskin primary fibroblasts from healthy donors (pro-
vided by A. Orecchia, IDI, Rome, Italy) were used at early
passages (from p5 to p10), unless otherwise specified. HeLa
(ATCC CCL-2), 293T (ATCC CRL-11268), BJ-hELT cells and
HPFs were cultured in DMEM (Invitrogen) supplemented
with 10% FBS (Invitrogen). pCMV6-entry-AKTIP-MYC-FLAG
(Origene), pTR-UF5 (provided by N. Muzyczka, University of
Florida), or HDAC1-FLAG (Addgene, #13820) vectors were
transfected in 293T cells according to Piersanti et al. [26]; cell
extracts were analysed 72 h post-transfection, unless otherwise
indicated. Second-generation recombinant lentiviruses (LVs)
were produced and titrated for p24 antigen content and used
for infections as previously described [26]. The LV-shAKTIP,
LV-shTRF2 and LV-scramble (control, ctr) vectors were
described previously [23]; the transfer vector pCDHblast
MCSNard OST-LMNAD50 [17] (Addgene #22662) was used
to produce LV-progerin. The multiplicity of infection (moi)
used for all experiments was 3pg p24/cell on HPFs and 5pg
p24/cell on HeLa cells. Transductions were performed in com-
plete medium supplemented with 8 mg ml21 polybrene
(Sigma). After viral addition, cells were centrifuged for 30 min
at 1800 r.p.m. at RT, incubated for 3 h at 378C, and then trans-
ferred to fresh complete medium. Seventy-two hours
post-infection, cells transduced with LVs obtained with
pLKO.1-derived transfer vectors were subjected to selection in
complete medium supplemented with 2 mg ml21 puromycin
(Sigma) and kept under these conditions for further analyses.
Seventy-two hours post-transduction, cells transduced with
LV-progerin were subjected to selection in complete medium
supplemented with 10 mg ml21 blasticidin (Sigma) and kept
under these conditions for further analyses.
HeLa cells were synchronized at the G1/S boundary by a
double-thymidine block. Cells were treated with 2 mM thymi-
dine for 14 h, released in fresh medium for 10 h and treated
again with 2 mM thymidine for 14 h. After double-thymidine
treatment, cells were released in fresh medium and collected
at the indicated time points.
MADA skin fibroblasts were obtained from a 12-year-old
patient carrying the Arg527His LMNA homozygous mutation.
Cell cultures were established and grown in DMEM-F12 (Gibco,
Life Technologies) supplemented with 10% fetal bovine serum
(Gibco, Life Technologies), 1% penicillin/streptomycin and 1%
L-glutamine. The experiments were performed on cells at p12.
HGPS fibroblasts were obtained from a patient carrying the
G608G LMNA mutation [27] and were maintained in culture
in DMEM supplemented with 10% fetal calf serum (Gibco)
and 1% penicillin/streptomycin. Skin biopsies were obtained
from patients and donors according to local and EU ethical
rules following informed consent.2.2. Western blotting
Whole protein extracts were obtained by treating cell pellets
with lysis buffer (20 mM HEPES pH 7.5, 150 mM NaCl,
5 mM MgCl2, 0.5 mM EGTA, 0.25% NP-40, 1 mM DTT,
0.5 mM PMSF, 0.5 mM Na3VO4 and protease inhibitor cocktail,
Roche). Samples were loaded onto pre-cast 4–12% gradient
acrylamide gels (NuPage, Invitrogen). After electro-blotting,
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3filters were incubated for 1 h with mouse monoclonal
anti-AKTIP (1 : 400, Sigma), goat anti-actin-HRP conjugated
(1 : 3500, Santa Cruz), mouse anti-lamin A/C (1 : 200, Santa
Cruz), goat anti-lamin B1 (1 : 200, Santa Cruz), mouse anti-
FLAG-HRP (1 : 1000; Sigma), rabbit anti-matrin 3 (1 : 1000,
Santa Cruz), goat anti-importin 7 (1 : 200, Santa Cruz), mouse
anti-trimethyl H3K9me3 (1 : 350, Millipore) and rabbit anti-
TRF2 (1 : 3500, Novus Biologicals). Filters were then incubated
with appropriate HRP-conjugated secondary antibodies (Santa
Cruz; diluted according to the manufacturer’s instructions),
which were detected using the enhanced chemiluminescence
system (ECL Plus, Amersham). Bands were imaged with the
ChemiDoc MP imager (Bio-Rad) and band intensities were
quantified using the IMAGE LAB software (Bio-Rad).
2.3. Mass spectrometry
Seventy-two hours after transfection with the AKTIP-FLAG,
pTR-UF5 or HDAC1-FLAG (Addgene, #13820) vectors in
293T cells, extracts were obtained by lysing the cells with
20 mM Hepes pH 7.5, 150 mM NaCl, 5 mM MgCl2, 0.5 mM
EGTA, 0.25% NP-40, 1 mM DTT, 0.5 mM PMSF, 0.5 mM
Na3VO4 in the presence of a protease inhibitor cocktail
(Roche). Immunoprecipitation was performed by incubation
of 2 mg of protein extract with 5 mg of anti-FLAG M2 antibody
(Sigma) or 5 mg of mouse IgG (Sigma), both conjugated to G-
sepharose four fast flow beads (GE Healthcare). Precipitated
complexes were eluted using acid glycine (pH 2.5) and 2%
Triton X-100 (Sigma) and then resuspended in SDS/PAGE
loading buffer (Invitrogen). For mass spectrometry (MS),
samples were separated onto pre-cast 4–12% gradient acryl-
amide gels (NuPage, Invitrogen). Entire gel lanes were cut
into 10 similar slices, subjected to in-gel tryptic digestion,
and used for LC-MS/MS analysis. Raw spectra were analysed
by BIOWORKS BROWSER 3.3.1. When proteins were present both in
anti-FLAG and in anti-IgG antibody samples, they were
selected by applying the emPAI ratio [28] equal or higher
than 1.5. The UNIPROT IDs of putative AKTIP interactors
were uploaded in the Protein Knowledgebase (UniProtKB)
and categorized based on Gene Ontology (GO) annota-
tion terms by using Cytoscape v 2.8.3 (see the electronic
supplementary material for full MS methods).
2.4. GST pulldown
AKTIP-GST and AKTIP-GST truncations were previously
described [23]. Protein purification and GST pulldown from
293T cell extracts were carried out as previously described
[23]. Immunoblotting was performed as described above.
2.5. Immunostaining
If not otherwise specified, for immunostaining of interphase
nuclei samples were pre-permeabilized as previously described
[23], fixed with 3.7% formaldehyde for 10 min at 48C, and permea-
bilized with 0.25% Triton X-100 in PBS for 1 min. Mitotic cells were
fixed in the same way omitting the pre-permeabilization step.
Samples were then blocked with 3% BSA and incubated for 1 h
with the following primary antibodies all diluted in 1% PBS–
BSA: mouse anti-AKTIP (1 : 20, Sigma), mouse anti-FLAG-HRP
(1 : 500, Sigma), goat anti-lamin B1 (1 : 50, Santa Cruz
Biotechnology), goat anti-lamin A/C (1 : 100, Santa Cruz), rabbit
anti-lamin A (1 : 200, Santa Cruz), mouse monoclonala-tubulin-FITC conjugated (1 : 100, Sigma) and rabbit anti g-
tubulin (1 : 200, Sigma). Cells were then incubated for 45 min at
RT with the following secondary antibodies diluted in PBS:
FITC-conjugated anti-mouse (1 : 30, Jackson Immunoresearch),
Alexa 555 anti-rabbit (1 : 200, Invitrogen), Alexa 568-anti-
mouse (1 : 200, Invitrogen) or rhodamine-conjugated anti-mouse
(1 : 30, Jackson Immunoresearch) or rhodamine-conjugated anti-
goat (1 : 30, Santa Cruz) or FITC-conjugated anti-goat (1 : 50,
Jackson Immunoresearch). After air drying, cells were mounted
with DAPI-Vectashield (Vector Laboratories). All images were
captured using a CoolSnap HQ CCD camera (Photometrics;
Tucson, AZ, USA) connected to a Zeiss Axioplan fluorescence
microscope equipped with an HBO 100 W mercury lamp.
SA-b-gal staining was carried out according to Dimri et al.
[29]. Cells at different days post-infection were plated on cov-
erslips for 24 h and then stained using the Senescent cell
Histochemical Staining Kit (Sigma).
For prelamin immunostaining, distorted nuclei observation
and chromatin analysis, cells were fixed in 100% methanol at
2208C for 7 min or in 4% paraformaldehyde at RT for 10 min.
Preparations were then incubated with goat anti-prelamin
A (1 : 100, C-20, Santa Cruz) and rabbit anti-trimethyl
H3K9 (1 : 100, Millipore) both diluted in PBS. Primary anti-
bodies were detected by 1 h incubation with Alexa Fluor
568-conjugated anti-goat (1 : 800 in PBS, Invitrogen) and Alexa
Fluor 488-conjugated anti-rabbit (1 : 500 in PBS, Invitrogen).
2.6. Flow cytometry
5-bromo-deoxyuridine (BrdU) at a final concentration of 45 mM
was added to the culture medium 30 min before harvesting the
cells. Cells were fixed in 70% ethanol, washed twice in PBS þ
0.5% Tween 20, and incubated in 3 M HCl for 45 min. Cells
were then exposed to anti-BrdU monoclonal antibody
(Dako), to the secondary Alexa-Fluor488-conjugated antibody
(Jackson) and counterstained with propidium iodide (PI,
Sigma) in the presence of 1 mg ml21 DNAse-free RNAse
(Sigma) for 30 min at room temperature. Acquisition was
carried out using a Beckman-Coulter Epics XL flow-cytometer
and recorded data were analysed with the WINMDI
software (developed by Joe Trotter; free download at http://
en.bio-soft.net/other/WinMDI.html).
2.7. mRNA quantification
One-week post-transduction, cells were lysed by addition of
TRIzol reagent (Invitrogen) and RNA extracted according to
the manufacturer’s instructions. After DNase treatment (Invi-
trogen), RNA was reverse transcribed into cDNA using an
oligo d(T) primer and the Omniscript RT kit (Qiagen). To quan-
tify target gene expression, specific primers (electronic
supplementary material, table S1) were selected using PRIMER
EXPRESS software (Applied Biosystems). Reactions were carried
out as previously described [30].3. Results
3.1. AKTIP binds nuclear envelope and nuclear matrix
proteins
As a first step towards the identification of AKTIP-interacting
partners, we analysed by MS the proteins that co-purify with
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Figure 1. Identification of AKTIP-interacting proteins. (a) AKTIP-FLAG-interacting proteins immunoprecipitated from 293T whole-cell extracts with anti-FLAG anti-
body or IgG were subjected to MS. Raw data were analysed with the BIOWORKS BROWSER v,3.3.1 software. Number of peptides, score and protein probability are
reported. Selected proteins are ordered by emPAI values, to a minimum of 0.1 (see the electronic supplementary material for a full list of interactors). (b) Subcellular
locations of AKTIP interactors obtained using UniProtKB. (c) Functional enrichment of AKTIP interactors, evaluated using Cytoscape 2.8.3. CC, Cellular Components; BP,
Biological Processes, FDR, false discovery rate.
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4AKTIP. 293T cells were transfected with a vector encoding an
AKTIP-FLAG fusion protein [23], or a control HDAC1-FLAG
expression plasmid, or an empty pTR-UF5 vector. Previous
work has shown that AKTIP-FLAG accumulates at the
nuclear rim just as the untagged AKTIP protein [23] (see
also electronic supplementary material, figure S1A). The
AKTIP-FLAG fusion protein also displayed the expected mol-
ecular weight and was detected by both anti-FLAG and anti-
AKTIP antibodies (electronic supplementary material, figure
S1b). Seventy-two hours after transfection, we precipitated
AKTIP-FLAG from whole-cell extracts using an anti-FLAG
antibody; MS was carried out on immunoprecipitates follow-
ing polyacrylamide gel electrophoresis (electronic
supplementary material, figure S1B). To detect AKTIP bona
fide interactors and eliminate false positives, we filtered raw
data from three independent experiments using the BIOWORKS
BROWSER 3.3.1 software (see Material and methods). These
analyses led to the identification of 45 AKTIP-interacting
proteins (figure 1a and electronic supplementary material,
figure S2). Using UniProtKB, we found that these proteins loca-
lize in the nucleus (31%), in the nucleus and the cytoplasm
(13%), in the cytoplasm (29%) or in the mitochondria (25%)
(figure 1b). Cytoscape enrichment analysis further revealed
that the nucleus and especially the nuclear lamina are GO
categories significantly overrepresented among AKTIP-
interacting partners (figure 1c). AKTIP-interacting proteins
included lamins B1, B2 and A/C (figure 1a), importin 7, a
nuclear-pore-associated b-family import receptor [31] and
matrin 3, an internal nuclear matrix component that inter-
acts with lamin A [32] (electronic supplementary material,
figure S2).
To validate these MS data, we performed a pulldown assay
using bacterially purified AKTIP-GST to capture proteins
from 293T cell extracts. Consistent with the MS data, pre-
cipitates included lamins B1 and A/C, matrin 3 and importin
7. In addition, we found that an anti-FLAG antibodyprecipitates lamin B1 from AKTIP-FLAG-expressing 293T
cells (figure 2a–c).
We next determined the AKTIP region(s) that interact with
the nuclear envelope proteins. We used three AKTIP trunca-
tions fused with GST including the N-terminal disordered
region (aa 1–70), the central region comprising the UEV por-
tion (aa 70–189) and the C-terminus consisting of 2 a-helices
and a distal disordered portion (aa 190–292) (figure 2d) [23].
GST pulldown showed that only the central region of AKTIP
interacts with A- and B-type lamins, importin 7 and matrin 3
(figure 2e,f).
3.2. AKTIP partially co-localizes with lamins
Previous work has shown that A- and B-type lamins form two
prominent nuclear meshworks with points of co-localization
during interphase [33]. During mitosis, after dissolution of
the nuclear lamina, A-type lamins exhibit a diffuse localization.
By contrast, B-type lamins associate with the spindle matrix,
where they are thought to provide a scaffold to promote micro-
tubule assembly and lamina reorganization at the nuclear
periphery at the end of mitosis [9,10]. Given the interaction
between AKTIP and lamins, we investigated AKTIP localiz-
ation. We immunostained with an anti-AKTIP antibody
HeLa cells harvested at different times after release from syn-
chronization at the G1–S boundary by a double-thymidine
block. We found that at all time points tested AKTIP was
enriched at the nuclear rim, suggesting that this localization
pattern is dominant during the cell cycle (figure 3a).
We next investigated whether AKTIP co-localizes with A-
and B-type lamins in interphase nuclei. The analysis of HPFs
stained for both AKTIP and lamin B1 showed that the two
proteins have multiple co-localization points, both at the
nuclear rim and in the nucleoplasm (figure 3b). Double stain-
ing of HPFs for AKTIP and either lamin A or lamin A/C
showed a partial co-localization of AKTIP with A-type
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Figure 2. AKTIP interacts with lamins and with other nuclear proteins. (a,b) Purified AKTIP-GST or GST alone was used to pull down AKTIP-interacting proteins from
293T extracts. Western blotting shows that lamin A/C and lamin B1 (a) along with importin 7 and matrin 3 (b) interact with AKTIP-GST but not with GST alone.
(c) Co-IP from extracts of 293T cells expressing AKTIP-FLAG showing that AKTIP and lamin B1 interact in vivo. (d ) Schematic of AKTIP-GST truncations used in GST
pulldown experiment from 293T cell extracts. These truncations include a disordered region at the N-terminus (black), the central region including the UEV portion
(green) and a C-terminal region comprising 2 a-helices (red) and a disordered region (black). (e,f ) Western blots showing that lamin A/C and lamin B1 (e) along
with importin 7 and matrin 3 ( f ) interact with the central region of AKTIP.
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5lamins at the nuclear periphery (figure 3b). We also observed
partial colocalization of AKTIP intranuclear signals with
lamin A/C signals (figure 3b).
To determine AKTIP localization during mitosis, we
used a fixative containing 0.25% Triton X-100. This fixative
results in a high level of protein extraction allowing a clear
visualization of AKTIP, but it does not fully preserve spindle
microtubules. We analysed AKTIP localization in BJ-hELT (BJ
fibroblasts expressing hTERT and SV40 Large T) and HeLa
cells and HPFs (figure 3c–e and electronic supplementary
material, figure S4). In all cell types, antibody staining
detected specific AKTIP-enriched mitotic structures, which
were absent in AKTIP-depleted cells (shAKTIP) (figure 3d;
see the electronic supplementary material, figure S3 for
analysis of RNAi efficiency). The AKTIP signal was associ-
ated with structures at the cell poles that overlapped thespindle microtubules and the centrosomes. In addition,
AKTIP concentrated to the midbody, a transient structure
that connects the two daughter cells at the end of cytokinesis.
The midbody contains microtubules that overlap in a narrow
region at the centre of the structure. This region often appears
dark after tubulin immunostaining (dark zone), because it is
tightly associated with proteins that block antibody binding
to tubulin [34]. Remarkably, AKTIP precisely encircles the
dark zone of the midbody (figure 3d ), suggesting a possible
role of AKTIP in cytokinesis.
To ask whether AKTIP co-localizes with lamins during
mitosis, we co-immunostained HPFs for AKTIP and either
lamin A or B. As expected from previous work [9], lamin A
did not co-localize with the AKTIP-enriched structures and
was instead diffuse (figure 3e). By contrast, lamin B1 accumu-
lated at the centrosomes and partially co-localized with
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6AKTIP, which was enriched at both the centrosomes and the
spindle (figure 3e,f ).
3.3. Functional relationships between lamins and AKTIP
Given the connection between AKTIP and lamins, we investi-
gated the functional relationships between these proteins. We
first asked whether mutations in lamin genes affect AKTIP
localization. We analysed AKTIP localization in HPFs from
patients affected by HGPS or MAD type A (MADA). The
HGPS mutation exposes a cryptic splice site in the LMNAgene, leading to a lamin A form deleted of 50 aa and perma-
nently farnesylated [35,36]. MADA cells, which carry the
R527H LMNA mutation that replaces an arginine with a histi-
dine at position 527, are characterized by accumulation of
prelamin A and progeroid traits [37]. In addition, we examined
AKTIP localization in HPFs transduced with a progerin-coding
lentivector (LV-progerin; electronic supplementary material,
figure S5). Immunostaining for AKTIP showed that in
untreated control cells AKTIP is enriched in both the cytoplasm
and the nucleus (particularly at the nuclear rim), while in
detergent-extracted control cells AKTIP localization was
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Figure 4. Abnormal AKTIP localization in lamin A mutant cells. Unextracted (a) or detergent-extracted (b) HGPS or MADA patient-derived fibroblasts, LV-progerin
( progerin-expressing) HPFs and LV-control (ctr) or mock-treated HPFs stained for AKTIP and DNA (DAPI). Note that the AKTIP signals in the cytoplasm (a) and at the
nuclear rim (b) of HGPS cells, MADA and progerin-expressing HPFs are weaker and more discontinuous than those observed in controls. In MADA nuclei, the AKTIP
signal is almost undetectable.
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7restricted to the nucleus (figure 4a,b). In unextracted LV-
progerin cells expressing both endogenous lamin A and
progerin, and more effectively in unextracted HGPS cells,
which are heterozygous for the LMNA mutation, the AKTIP
signal in the cytoplasm was reduced and the nuclear rim
staining was weaker and more discontinuous than in controls
(figure 4a); the defective AKTIP localization at the nuclear
rim of these cells was more evident in preparations extracted
with Triton X-100 (figure 4b). In MADA cells, homozygous
for the LMNA mutation, AKTIP was almost undetectable
(figure 4a,b).
We next investigated whether loss of AKTIP affects lamin
expression. We reduced the AKTIP level by RNAi in early pas-
sage HPFs and HeLa cells (electronic supplementary material,
figure S3). Western blotting performed on extracts from both
cell types collected at 7 days post-infection showed that
AKTIP depletion results in a substantial decrease in lamin A
compared with control cells, without affecting lamin C and
lamin B1 levels (figure 5a–d ). In addition, Q-PCR-mediated
mRNA quantification in HeLa cells at 7 days after shAKTIP
infection showed a significant decrease in the lamin A
mRNA level compared to control (figure 5e). However,
AKTIP deficiency did not affect the level of lamin C mRNA,
which is the main alternative splicing product of the LMNA
gene. Consistent with these results, lamin A immunostaining
in AKTIP-depleted HeLa cells showed a substantial reduction
of the lamin A signal, which, however, maintained its normal
association with the nuclear rim (figure 5f).
We have previously shown that AKTIP is required for telo-
mere replication and that its depletion generates telomere-
associated DNA repair foci [23]. Depletion of the TRF2
shelterin component, which physically interacts with lamin
A/C [6], also causes telomere dysfunction and triggers theDDR [38]. We thus wondered whether lamin A reduction
observed in AKTIP-depleted cells could be generated by dys-
functional telomeres. To test this possibility, we monitored
lamin expression in shTRF2 HeLa cells. TRF2 depletion did
not result in lamin A/C reduction, indicating that the effect
of AKTIP depletion on lamin A is specific and not a general
consequence of DDR triggered by dysfunctional telomeres
(electronic supplementary material, figure S6).3.4. AKTIP depletion results in cell senescence
Lamin mutations cause defects in nuclear structure, variations
in heterochromatic marks and cell senescence [3]. These
findings prompted us to inquire whether AKTIP depletion
generates the same phenotypic traits elicited by LMNA
mutations. Cell labelling with the empirical senescence
marker SA-bgal [29] revealed that early passage HPFs (p6) at
11 and 13 days after shAKTIP infection (electronic supplemen-
tary material, figure S3a) exhibit a significant increase in
senescent cells compared with controls (figure 6a,b). We next
analysed K9 trimethylation of histone H3 (trimethyl H3K9),
an epigenetic marker of cell senescence that is reduced in pre-
maturely ageing lamin-defective cells [39]. Early passage
wild-type cells show a clustered intranuclear distribution of tri-
methyl H3K9, while senescent cells exhibit a more diffuse
distribution of this trimethylated histone [14,37,39]. Early
(p6) and mid-late (p12) passage AKTIP-depleted HPFs (elec-
tronic supplementary material, figure S3a) displayed higher
frequencies of nuclei with diffuse trimethyl H3K9 distribution
than passage-matched controls (figure 6c,d). In addition, Wes-
tern blotting showed that in AKTIP-depleted early passage
(p6) HPFs, the trimethyl H3K9 level was reduced with respect
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8to controls and was comparable to that observed in naturally
aged HPFs at p22 (figure 6e).
Previous studies on naturally aged cells have shown that
they accumulate unprocessed lamin A (prelamin A) [40]. This
accumulation exacerbates the disease traits in HGPS and
MADA patients, and eventually leads to nuclear deformation
[12,14]. To ask whether AKTIP depletion results in a similar
phenotype, we treated HPFs at different passages (p6 and
p22) with shAKTIP (electronic supplementary material,
figure S3a) and examined 7 days post-infection cells immu-
nostained with the C20 antibody, which specifically reacts
with prelamin A. shAKTIP HPFs at p22 displayed a higher
frequency of prelamin A-positive cells than passage-matched
control HPFs (figure 7a,b). We also examined AKTIP-
deficient HPFs for distorted nuclei, which have been
described in lamin mutant cells [12,14,39]. We found that
AKTIP-depleted HPFs at p22 exhibit a significantly higher
frequency of distorted nuclei than control cells (figure 7c,d ).
Taken together, these data indicate that AKTIP depletion
results in phenotypic traits that are characteristically associ-
ated with lamin A mutations.4. Discussion
We have recently shown that AKTIP interacts with the PCNA
and RPA70 components of the DNA replication machinery andwith the shelterin subunits TRF1 and TRF2. Consistent with
these results, we found that AKTIP is required for both general
DNA replication and telomere replication [23]. Our MS exper-
iments have shown that AKTIP also interacts with A- and
B-type lamins, matrin 3, importin 7 and several mitochondrial
proteins. The AKTIP interaction with lamins, matrin 3 and
importin 7 was further validated by GST pulldown.
We focused on the relationships between AKTIP and
lamins and found that these proteins exhibit similar localiz-
ation patterns in interphase nuclei, with AKTIP enriched at
the nuclear rim, showing partial co-localization with both
the A- and B-lamin meshworks. We also found that AKTIP
is enriched in structures that partially co-localize with the
centrosomes and the spindle of mitotic cells. In addition,
AKTIP forms a ring around the midbody during late cytokin-
esis. Previous studies in different cell types have shown that
lamin B is also enriched at the centrosomes and spindle poles
[10,41,42] as well as at the midbody [43]. It has been
suggested the lamin network is part of the spindle matrix,
a membranous network that favours spindle morphogenesis
[10,42]. Thus, it appears that AKTIP and lamins are enriched
in the same cellular compartments, a finding that suggests a
functional interaction among these proteins.
Indeed, we found that AKTIP knockdown results in a
specific reduction of lamin A at both the mRNA and the
protein level. A specific downregulation of A-type lamins
has been also found in other systems. For example, in
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10mouse brains both lamin A and progerin expression is
downregulated by miR-9, a brain-specific microRNA; miR-9
targets prelamin A 30-UTR but not the lamin C transcript
[44]. Lamin A and prelamin A downregulation and autopha-
gic degradation have been also detected in response to
retinoic acid and rapamycin treatments, in the absence of
concomitant lamin C variations [27,45]. Our current results
do not allow us to envisage a precise model to explain how
AKTIP-deficient cells specifically downregulate lamin A
expression. It is possible that loss of AKTIP lowers the pro-
duction of lamin A by affecting the splicing of LMNA RNA
or by controlling both prelamin A degradation and LMNA
gene expression [46]. It is also conceivable that the prelamin
A mRNA is downregulated by a microRNA. However, this
hypothetical microRNA cannot be miR-9, because it was not
found in HeLa cells [44]. The most intriguing aspect of the
AKTIP-mediated regulation of prelamin A mRNA is that
AKTIP interacts physically with both lamin A/C and lamin
B. This finding raises the enthralling possibility that AKTIP
regulates prelamin A mRNA expression through an interaction
with one or more lamin types.
We also found a modest increase (from 3 to 9%) in the fre-
quency of prelamin A-positive cells in late passage samples of
AKTIP-depleted cells. This finding is in apparent contrast
with the downregulation of lamin A observed in in early pas-
sage AKTIP-depleted cells. However, it should be considered
that prelamin A accumulation reflects a slowdown in prela-
min A processing, a phenomenon that characterizes the
senescent phenotype associated with physiological and pre-
mature ageing [47]. It is thus possible that the accelerated
senescence of AKTIP-depleted cells strongly affects prelamin
A processing leading to an accumulation of this protein even
in cells in which level of lamin A mRNA was initially reduced
compared with controls.
We showed that AKTIP is mislocalized in LV-progerin
and HGPS cells and in cells from MADA patients that accumu-
late prelamin A [12,14,39]. These findings raise the possibility
of a role of AKTIP in progerin-induced pathogenesis. Another
possible contributing factor to HGPS pathogenesis is the laminA-interacting LAP2a protein [48,49]. It has been also shown
that LAP2a transiently binds telomeres [50] and that progerin
has the ability to reduce LAP2a association with telomeres [48].
Here, we have not addressed the relationships between AKTIP
and LAP2a but we have shown that in HGPS cells the nuclear
localization of AKTIP is strongly reduced compared with
controls, suggesting a possible effect on proper telomere
replication. These data, together with the cellular senescence
observed in AKTIP-depleted cells, reinforce the idea of a
functional interconnection between lamins and AKTIP and
support the hypothesis of a possible involvement of AKTIP
in progeroid syndromes.
Our MS analyses, in addition to lamins, identified matrin
3, importin 7 and several mitochondrial proteins as AKTIP
partners. The functional relationships between AKTIP and
these interacting partners deserve further investigation. In
this respect, it should be noted that previous studies have
shown that proteins involved in telomere maintenance such
as the ATM kinase and the shelterin subunit TIN2 localize
to mitochondria and regulate mitochondrial activity [14,51].
Altogether, our results identify AKTIP as a new lamin
interactor, expanding the connection between telomeres and
lamins and, more in general, between telomeres and nuclear
envelope. In addition, the interplay between AKTIP and both
lamin A and its aberrant forms responsible for HGPS and
MADA suggests a possible involvement of AKTIP in the
pathogenesis of these diseases.Ethics. Skin biopsies were obtained from patients and donors according
to local and EU ethical rules following informed consent.
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